These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Effect of endogenous GLP-1 on insulin secretion in type 2 diabetes. Salehi M, Aulinger B, Prigeon RL, D'Alessio DA. Diabetes; 2010 Jun; 59(6):1330-7. PubMed ID: 20215429 [Abstract] [Full Text] [Related]
7. Biological activity of AC3174, a peptide analog of exendin-4. Hargrove DM, Kendall ES, Reynolds JM, Lwin AN, Herich JP, Smith PA, Gedulin BR, Flanagan SD, Jodka CM, Hoyt JA, McCowen KM, Parkes DG, Anderson CM. Regul Pept; 2007 Jun 07; 141(1-3):113-9. PubMed ID: 17292977 [Abstract] [Full Text] [Related]
8. Glucagon-like peptide-1 augments insulin-mediated glucose uptake in the obese state. Egan JM, Meneilly GS, Habener JF, Elahi D. J Clin Endocrinol Metab; 2002 Aug 07; 87(8):3768-73. PubMed ID: 12161508 [Abstract] [Full Text] [Related]
9. The pathophysiology of diabetes involves a defective amplification of the late-phase insulin response to glucose by glucose-dependent insulinotropic polypeptide-regardless of etiology and phenotype. Vilsbøll T, Knop FK, Krarup T, Johansen A, Madsbad S, Larsen S, Hansen T, Pedersen O, Holst JJ. J Clin Endocrinol Metab; 2003 Oct 07; 88(10):4897-903. PubMed ID: 14557471 [Abstract] [Full Text] [Related]
17. Blood glucose control in healthy subject and patients receiving intravenous glucose infusion or total parenteral nutrition using glucagon-like peptide 1. Nauck MA, Walberg J, Vethacke A, El-Ouaghlidi A, Senkal M, Holst JJ, Gallwitz B, Schmidt WE, Schmiegel W. Regul Pept; 2004 Apr 15; 118(1-2):89-97. PubMed ID: 14759561 [Abstract] [Full Text] [Related]
18. Normalization of glucose concentrations and deceleration of gastric emptying after solid meals during intravenous glucagon-like peptide 1 in patients with type 2 diabetes. Meier JJ, Gallwitz B, Salmen S, Goetze O, Holst JJ, Schmidt WE, Nauck MA. J Clin Endocrinol Metab; 2003 Jun 15; 88(6):2719-25. PubMed ID: 12788879 [Abstract] [Full Text] [Related]
19. A novel exendin-4 human serum albumin fusion protein, E2HSA, with an extended half-life and good glucoregulatory effect in healthy rhesus monkeys. Zhang L, Wang L, Meng Z, Gan H, Gu R, Wu Z, Gao L, Zhu X, Sun W, Li J, Zheng Y, Dou G. Biochem Biophys Res Commun; 2014 Mar 07; 445(2):511-6. PubMed ID: 24565847 [Abstract] [Full Text] [Related]